TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32896504

Group type: EXPERIMENTAL
Intervention: Hormone group (3‐day, low‐dose glucocorticoid treatment plus conventional treatment; 63 patients)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control group (conventional treatment only; 62 patients)
Number of subjects: 125
Study: 32705460

Group type: EXPERIMENTAL
Intervention: Parent Management Training-Oregon model (PMTO)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Family-based services as usual (SAU)
Number of subjects: 126
Study: 35901309

Group type: EXPERIMENTAL
Intervention: Second glaucoma drainage device (SGDD)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Transscleral cyclophotocoagulation (CPC)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: SGDD
Number of subjects: 42
Study: 33124663

Group type: EXPERIMENTAL
Intervention: Rapamycin (4 weeks)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Rapamycin plus Vildagliptin (4 weeks of rapamycin plus 12 weeks of vildagliptin)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Double placebo (control group)
Number of subjects: 55
Study: 32404518

Group type: EXPERIMENTAL
Intervention: +F+H
Number of subjects: 89

Group type: COMPARATOR
Intervention: -F-H
Number of subjects: 89

Group type: COMPARATOR
Intervention: -F+H
Number of subjects: 89
Study: 34890936

Group type: EXPERIMENTAL
Intervention: Radiomics model based on pre-NAC MRI features (model 1)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Radiomics model based on post-NAC MRI features (model 2)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Radiomics model based on both pre- and post-NAC MRI features (model 3)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Clinical model for predicting systemic recurrence
Number of subjects: 147

Group type: COMPARATOR
Intervention: Comparison of model 3 to clinical model
Number of subjects: 147
Study: 34301334

Group type: EXPERIMENTAL
Intervention: Structured group programme and access to online resources
Number of subjects: 92

Group type: COMPARATOR
Intervention: Access to online resources only
Number of subjects: 92
Study: 34678491

Group type: EXPERIMENTAL
Intervention: 9vHPV vaccine
Number of subjects: 6000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6000
Study: 33769174

Group type: EXPERIMENTAL
Intervention: Low-dose acetylsalicylic acid (ASA) 100 mg/day
Number of subjects: 277

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 277
Study: 32767679

Group type: EXPERIMENTAL
Intervention: PF-06763809 (2.3%, 0.8%, 0.23%)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Betamethasone
Number of subjects: 17

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Calcipotriol
Number of subjects: 17
Study: 35459446

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) treatment
Number of subjects: 169

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 169
Study: 34959879

Group type: EXPERIMENTAL
Intervention: BOLD+
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: BOLD
Number of subjects: 27

Group type: COMPARATOR
Intervention: HAD
Number of subjects: 27

Group type: COMPARATOR
Intervention: DASH
Number of subjects: 27
Study: 36123366

Group type: EXPERIMENTAL
Intervention: Atezolizumab 840 mg every 2 weeks for 5 cycles (4 weeks/cycle) plus weekly nab-paclitaxel for 3 cycles, followed by atezolizumab 1200 mg every 3 weeks for 11 cycles after surgery.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo with weekly nab-paclitaxel for 3 cycles, followed by standard of care.
Number of subjects: 0
Study: 33620131

Group type: EXPERIMENTAL
Intervention: Cimlanod (BMS-986231)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Nitroglycerin (NTG)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Cimlanod and NTG
Number of subjects: 45
Study: 33104756

Group type: EXPERIMENTAL
Intervention: AKI group (patients who met KDIGO criteria for AKI)
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: AKI group
Number of subjects: 253

Group type: COMPARATOR
Intervention: Male sex
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Presence of comorbid hypertension
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Presence of chronic kidney disease
Number of subjects: 253

Group type: COMPARATOR
Intervention: Female sex
Number of subjects: 253
Study: 36425922

Group type: EXPERIMENTAL
Intervention: Superficial SAP block with 30 ml 0.375% ropivacaine (group S)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Deep SAP block with 30 ml 0.375% ropivacaine (group D)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Superficial SAP block (group S)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Deep SAP block (group D)
Number of subjects: 40
Study: 33541759

Group type: EXPERIMENTAL
Intervention: Regular group supervision
Number of subjects: 134

Group type: COMPARATOR
Intervention: Individual telephone supervision based on only the behavioral component of a feedback protocol
Number of subjects: 134

Group type: COMPARATOR
Intervention: Individual telephone supervision based on the full protocol
Number of subjects: 134

Group type: COMPARATOR
Intervention: Objective feedback
Number of subjects: 134
Study: 32865380

Group type: EXPERIMENTAL
Intervention: Colchicine 0.5 mg once daily
Number of subjects: 5522

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5522
Study: 32996671

Group type: EXPERIMENTAL
Intervention: Topical oral vitamin D gel
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Topical oral vitamin D gel plus conventional treatment
Number of subjects: 45

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Combined therapy group (vitamin D gel + conventional treatment)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Vitamin D group
Number of subjects: 45
Study: 33261257

Group type: EXPERIMENTAL
Intervention: Physical therapy
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Oral corticosteroids
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Injections of corticosteroids
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Injective therapy with local anaesthetics
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 55
Study: 34514743

Group type: EXPERIMENTAL
Intervention: Complex visual scene search task ('Where's Waldo?')
Number of subjects: 20

Group type: COMPARATOR
Intervention: Simple visual shapes presented at 0.5-, 2-, and 4-s intervals
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Engagement self-reported by participants (1 to 10 scale)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: All tasks (including both complex and simple)
Number of subjects: 20
Study: 32134286

Group type: EXPERIMENTAL
Intervention: IMARA intervention
Number of subjects: 199

Group type: COMPARATOR
Intervention: Health promotion control group
Number of subjects: 199
Study: 32431170

Group type: EXPERIMENTAL
Intervention: Electronic health records (EHR)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Paper-based handwritten documentation (HWD)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: EHR
Number of subjects: 30

Group type: COMPARATOR
Intervention: HWD
Number of subjects: 30
Study: 33121297

Group type: EXPERIMENTAL
Intervention: High polyphenol extra-virgin olive oil (EVOO)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Low polyphenol refined olive oil (ROO)
Number of subjects: 40
Study: 32768713

Group type: EXPERIMENTAL
Intervention: 1100 ppm Stannous fluoride (SnF2)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 1450 ppm MFP + calcium silicate + sodium phosphate (CSSP)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: CSSP + dual-phase gel (CSSP + Serum)
Number of subjects: 48

Group type: COMPARATOR
Intervention: non-fluoridated (NF)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: SnF2, CSSP, CSSP + Serum
Number of subjects: 48
Study: 35693609

Group type: EXPERIMENTAL
Intervention: Ultrathin bronchoscope (UTB) with virtual bronchoscopic navigation (VBN) and endobronchial ultrasound (EBUS)
Number of subjects: 578

Group type: COMPARATOR
Intervention: Thin bronchoscope (TB) with VBN and EBUS using guide sheath (GS)
Number of subjects: 578

Group type: COMPARATOR
Intervention: Thin bronchoscope (TB) with VBN and EBUS without guide sheath (non-GS)
Number of subjects: 578
Study: 33050947

Group type: EXPERIMENTAL
Intervention: Favipiravir 1800 mg BD on Day 1 followed by 800 mg BD for the next 13 days
Number of subjects: 190

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Favipiravir
Number of subjects: 190
Study: 35631072

Group type: EXPERIMENTAL
Intervention: ThymoQuinone Formula (TQF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33807284

Group type: EXPERIMENTAL
Intervention: Time-Restricted Eating (TRE) - ad libitum 8-h eating window
Number of subjects: 20

Group type: COMPARATOR
Intervention: Non-Time-Restricted Eating (non-TRE)
Number of subjects: 20
Study: 32463786

Group type: EXPERIMENTAL
Intervention: YMCA-DPP
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: VLM-DPP
Number of subjects: 158

Group type: COMPARATOR
Intervention: YMCA-DPP vs VLM-DPP
Number of subjects: 158
Study: 35922776

Group type: EXPERIMENTAL
Intervention: Lactase (600 FCC units/mL), 5 drops mixed with breast milk or formula feed, four times a day for 4 weeks
Number of subjects: 162

Group type: COMPARATOR
Intervention: Placebo, 5 drops mixed with breast milk or formula feed, four times a day for 4 weeks
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Lactase (600 FCC units/mL)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 162
Study: 34358734

Group type: EXPERIMENTAL
Intervention: Humphrey Field Analyzer (HFA)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Toronto Portable Perimeter (TPP)
Number of subjects: 91
Study: 32475460

Group type: EXPERIMENTAL
Intervention: Low-ME diet (3,111 kcal/kg ME)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: High-ME diet (3,383 kcal/kg ME)
Number of subjects: 50

Group type: COMPARATOR
Intervention: CST (Comparative Slaughter Technique)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Pair-feeding with varying percentages (50%, 60%, 70%, 80%, 90%) of lead bird's intake
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Low-ME diet and High-ME diet
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Additional measurements (shank temperature, feeding station visits)
Number of subjects: 50
Study: 34289778

Group type: EXPERIMENTAL
Intervention: Caregivers' perceived stress scores (PSS)
Number of subjects: 1797

Group type: EXPERIMENTAL
Intervention: Psychological symptoms in children
Number of subjects: 1797

Group type: EXPERIMENTAL
Intervention: Risk factors for higher caregivers’ PSS scores
Number of subjects: 1797
Study: 32755100

Group type: EXPERIMENTAL
Intervention: Vitamins C and E (400 IU/day of vitamin E and 1000 mg/day of vitamin C)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (iron tablets only)
Number of subjects: 160
Study: 36004739

Group type: EXPERIMENTAL
Intervention: Reboxetine (4 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Reboxetine (4 mg) + Oxybutynin (5 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 33502533

Group type: EXPERIMENTAL
Intervention: Meloxicam IV 30 mg
Number of subjects: 181

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 181
Study: 32739045

Group type: COMPARATOR
Intervention: Quick syringe changeover (QC)
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Double pumping changeover (DPC)
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Automated changeover (AC)
Number of subjects: 286
Study: 35373238

Group type: EXPERIMENTAL
Intervention: HFNC oxygenation at 60L/min
Number of subjects: 190

Group type: COMPARATOR
Intervention: Non-rebreather mask for preoxygenation and nasal prongs of at least 15L/min oxygen flow for apnoeic oxygenation
Number of subjects: 190

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 190
Study: 33533655

Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus definitive chemoradiotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus definitive chemoradiotherapy
Number of subjects: 0
Study: 34949631

Group type: EXPERIMENTAL
Intervention: Interactive SMS messaging intervention (Mobile WACh NEO)
Number of subjects: 5000

Group type: COMPARATOR
Intervention: No SMS (control)
Number of subjects: 5000
Study: 32362377

Group type: EXPERIMENTAL
Intervention: Self-carpal ligament stretching
Number of subjects: 83

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 83
Study: 37337241

Group type: COMPARATOR
Intervention: Empirical therapy (Bismuth quadruple therapy as first-line, high-dose dual therapy as rescue)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Susceptibility-guided sequential strategy (clarithromycin triple therapy for clarithromycin-sensitive strains, high-dose dual therapy for clarithromycin-resistant strains, levofloxacin quadruple regimen for levofloxacin-sensitive strains, furazolidone quadruple regimen for others)
Number of subjects: 500
Study: 32945620

Group type: EXPERIMENTAL
Intervention: Therapeutic play intervention (ITP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard education (SE)
Number of subjects: 20
Study: 32730913

Group type: EXPERIMENTAL
Intervention: Anterior Chamber Depth (ACD), Lens Vault (LV), Iris Curvature (IC) in model 1A
Number of subjects: 2225

Group type: EXPERIMENTAL
Intervention: Lens Vault (LV) and Axial Length in model 1B
Number of subjects: 2225
Study: 35313959

Group type: EXPERIMENTAL
Intervention: UC-MSCs infusion (3 doses of 5×10^5 cells/kg with a dosing interval of 48 hours)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 33687747

Group type: EXPERIMENTAL
Intervention: Molecularly-guided therapy
Number of subjects: 628

Group type: COMPARATOR
Intervention: Platinum-based chemotherapy
Number of subjects: 628
Study: 35500977

Group type: EXPERIMENTAL
Intervention: Pilates group (PG, n = 29)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (CG, n = 32)
Number of subjects: 61
Study: 36364884

Group type: EXPERIMENTAL
Intervention: Bioactive yoghurt containing curcumin and chlorogenic acid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo yoghurt
Number of subjects: 0
Study: 35397607

Group type: EXPERIMENTAL
Intervention: Checklist-based box system intervention (CBBSI)
Number of subjects: 2224

Group type: COMPARATOR
Intervention: Routine care (control)
Number of subjects: 2224

Group type: EXPERIMENTAL
Intervention: Knowledge about services during antenatal care visits
Number of subjects: 2224

Group type: EXPERIMENTAL
Intervention: High level of social support
Number of subjects: 2224
Study: 33797489

Group type: EXPERIMENTAL
Intervention: Video education program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no video education)
Number of subjects: 0
Study: 33436465

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT) via mobile app guidance
Number of subjects: 370

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 370
Study: 33290610

Group type: EXPERIMENTAL
Intervention: Tamoxifen (T)
Number of subjects: 911

Group type: EXPERIMENTAL
Intervention: Letrozole (L)
Number of subjects: 911

Group type: EXPERIMENTAL
Intervention: Tamoxifen followed by Letrozole (TL)
Number of subjects: 911

Group type: EXPERIMENTAL
Intervention: Letrozole followed by Tamoxifen (LT)
Number of subjects: 911

Group type: COMPARATOR
Intervention: All treatment arms (T, L, TL, LT)
Number of subjects: 911

Group type: EXPERIMENTAL
Intervention: Older patients (age 65 or older)
Number of subjects: 911

Group type: EXPERIMENTAL
Intervention: Tumors larger than 2 cm
Number of subjects: 911

Group type: EXPERIMENTAL
Intervention: 4 or more positive nodes
Number of subjects: 911

Group type: EXPERIMENTAL
Intervention: Progesterone receptor (PR)–negative tumors
Number of subjects: 911

Group type: EXPERIMENTAL
Intervention: Shorter disease-free survival (DFS)
Number of subjects: 911
Study: 33564684

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 80

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 80
Study: 35794660

Group type: EXPERIMENTAL
Intervention: Lisinopril/amlodipine tablets (test and reference)
Number of subjects: 92
Study: 34129252

Group type: EXPERIMENTAL
Intervention: Dapagliflozin (10 mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 32017643

Group type: EXPERIMENTAL
Intervention: Text-message reminders for second dose of influenza vaccine
Number of subjects: 256
Study: 35470256

Group type: EXPERIMENTAL
Intervention: Stabilisation exercise group (SEG) - exercise protocol twice a week for 12 weeks
Number of subjects: 14

Group type: COMPARATOR
Intervention: Regular exercise group (REG) - usual exercise routine
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Stabilisation exercise group (SEG)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Regular exercise group (REG)
Number of subjects: 14
Study: 32757879

Group type: EXPERIMENTAL
Intervention: Hybrid ultrasonic advanced bipolar device (HUB)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Ultrasonic coagulating shears
Number of subjects: 200
Study: 35359882

Group type: EXPERIMENTAL
Intervention: Hybrid closed-loop glucose control (CamAPS FX)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Sensor-augmented pump (SAP) therapy
Number of subjects: 38
Study: 34658160

Group type: EXPERIMENTAL
Intervention: Aerobic Training (AT)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Combination Training (CT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Resistance Training (RT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Stretching Attention Control (AC)
Number of subjects: 90
Study: 34788592

Group type: EXPERIMENTAL
Intervention: Robot-assisted surgery
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control manual surgery
Number of subjects: 12
Study: 33926665

Group type: EXPERIMENTAL
Intervention: Lung-volume-reduction surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 0
Study: 32284995

Group type: EXPERIMENTAL
Intervention: Online education platforms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blended instruction modalities
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional in-person instruction
Number of subjects: 0
Study: 36136232

Group type: EXPERIMENTAL
Intervention: Lasmiditan 50 mg
Number of subjects: 846

Group type: EXPERIMENTAL
Intervention: Lasmiditan 100 mg
Number of subjects: 846

Group type: EXPERIMENTAL
Intervention: Lasmiditan 200 mg
Number of subjects: 846

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 846
Study: 32927091

Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 24
Study: 35782699

Group type: EXPERIMENTAL
Intervention: Manual hyperinflation with suction
Number of subjects: 12

Group type: COMPARATOR
Intervention: Suction alone
Number of subjects: 12
Study: 34429172

Group type: EXPERIMENTAL
Intervention: Empowerment-Based Human Centered Educational Program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no educational program)
Number of subjects: 0
Study: 32943657

Group type: EXPERIMENTAL
Intervention: Cystoinflation (300 cc saline retro-fill)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Control (no retro-fill)
Number of subjects: 214
Study: 36107462

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 37668

Group type: COMPARATOR
Intervention: Placebo treatment in secondary prevention RCTs
Number of subjects: 37668
Study: 33002878

Group type: EXPERIMENTAL
Intervention: ED visits for TBI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hospital admission rate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Admission rate by sex
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fall-related TBI rates
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: In-ED mortality
Number of subjects: 0
Study: 35142923

Group type: EXPERIMENTAL
Intervention: ER-D (etch-and-rinse with dry dentin)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: ER-M (etch-and-rinse with moist dentin)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: SE-et (self-etch with selective enamel etching)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: SET (self-etch without selective enamel etching)
Number of subjects: 31
Study: 34180363

Group type: EXPERIMENTAL
Intervention: Cognitive remediation combined with vocational rehabilitation
Number of subjects: 37

Group type: COMPARATOR
Intervention: Vocational rehabilitation only
Number of subjects: 37
Study: 32279841

Group type: EXPERIMENTAL
Intervention: Bioresorbable vascular scaffold (BVS)
Number of subjects: 341

Group type: COMPARATOR
Intervention: Everolimus‐eluting stent (EES)
Number of subjects: 341
Study: 35895116

Group type: EXPERIMENTAL
Intervention: WiScope® Single use digital flexible ureteroscope
Number of subjects: 242

Group type: COMPARATOR
Intervention: Reusable flexible ureteroscope
Number of subjects: 242
Study: 32985775

Group type: EXPERIMENTAL
Intervention: Insulin glargine for 3 months followed by metformin for 9 months (G→Met)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Metformin alone (Met) for 12 months
Number of subjects: 91
Study: 33274381

Group type: EXPERIMENTAL
Intervention: Testosterone cream (10 mg daily for 10 weeks)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (1:1 for 10 weeks)
Number of subjects: 48
Study: 32553077

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen treatment (HBOT)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Medicine only
Number of subjects: 120
Study: 36409485

Group type: EXPERIMENTAL
Intervention: Posterior foraminotomy
Number of subjects: 265

Group type: COMPARATOR
Intervention: Anterior cervical discectomy with fusion
Number of subjects: 265
Study: 34459659

Group type: EXPERIMENTAL
Intervention: Amulet occluder
Number of subjects: 1878

Group type: COMPARATOR
Intervention: Watchman device
Number of subjects: 1878
Study: 32960179

Group type: EXPERIMENTAL
Intervention: Transcutaneous cervical vagus nerve stimulation (tcVNS)
Number of subjects: 24
Study: 33804207

Group type: EXPERIMENTAL
Intervention: Vertical platform training
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Rotational platform training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 60
Study: 33214190

Group type: COMPARATOR
Intervention: Rapid-acting insulin (RAI)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Human regular insulin (HRI)
Number of subjects: 136